PRNewsWire - Health

Real-world prospective data confirms improved risk stratification in multiple myeloma using SKY92 gene expression profiling
Shareholder Alert: Robbins LLP Informs Investors of the Rocket Pharmaceuticals, Inc. Class Action
Rockefeller Foundation Releases New Polling Data: Majority of Americans Want Food is Medicine Programs
Kelun-Biotech's Novel CLDN18.2 ADC SKB315 IND in Combination with Tagolizumab Receives NMPA Approval for the First-Line Treatment of Gastric/Gastro-oesophageal Junction Cancer